ES2052890T3 - Un metodo para la sintesis de compuestos aromaticos di- y trisubstituidos. - Google Patents

Un metodo para la sintesis de compuestos aromaticos di- y trisubstituidos.

Info

Publication number
ES2052890T3
ES2052890T3 ES89202429T ES89202429T ES2052890T3 ES 2052890 T3 ES2052890 T3 ES 2052890T3 ES 89202429 T ES89202429 T ES 89202429T ES 89202429 T ES89202429 T ES 89202429T ES 2052890 T3 ES2052890 T3 ES 2052890T3
Authority
ES
Spain
Prior art keywords
trisubstituted
synthesis
aromatic compounds
phenyl
alk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89202429T
Other languages
English (en)
Inventor
Johannes Hubertus Wieringa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Application granted granted Critical
Publication of ES2052890T3 publication Critical patent/ES2052890T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Eye Examination Apparatus (AREA)
  • Radio Relay Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)

Abstract

LA INVENCION RELATA UN COMPUESTO DE FORMULA GENERAL (I) DONDE R1 Y R2 SON INDEPENDIENTEMENTE HIDROGENO, NO2, OH, HALOGENO, ALQUIL C1-C4, ALCOXI C1-C4, UN AMINO INSUSTITUIDO O UN AMINO SUSTITUIDO ALQUILICO C1-C4; X REPRESENTA O, S, CH2, NH O NALK; A REPRESENTA CMH2M O CKH2KO; I ES DE 1 A 4; M ES DE 0 A 2; N ES DE 0 A 1; Q REPRESENTA UN HIDROGENO, FENIL O UN GRUPO ALK OPCIONALMENTE SUSTITUIDO POR FENIL DONDE ALK ES UN HIDROCARBONO ALIFATICO C1-C6; Y LA ADICION DE SALES AL MISMO.
ES89202429T 1988-10-10 1989-09-28 Un metodo para la sintesis de compuestos aromaticos di- y trisubstituidos. Expired - Lifetime ES2052890T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8802470 1988-10-10

Publications (1)

Publication Number Publication Date
ES2052890T3 true ES2052890T3 (es) 1994-07-16

Family

ID=19853017

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89202429T Expired - Lifetime ES2052890T3 (es) 1988-10-10 1989-09-28 Un metodo para la sintesis de compuestos aromaticos di- y trisubstituidos.

Country Status (16)

Country Link
US (1) US5051424A (es)
EP (1) EP0365064B1 (es)
JP (1) JPH02134374A (es)
KR (1) KR900006308A (es)
AT (1) ATE81651T1 (es)
AU (1) AU621408B2 (es)
CA (1) CA2000060A1 (es)
DE (1) DE68903263T2 (es)
DK (1) DK498889A (es)
ES (1) ES2052890T3 (es)
FI (1) FI894783A (es)
GR (1) GR3006821T3 (es)
IE (1) IE893129L (es)
NZ (1) NZ230934A (es)
PT (1) PT91932B (es)
ZA (1) ZA897551B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0598123A4 (en) * 1991-07-19 1995-02-15 Zeria Pharm Co Ltd PIPERAZINE DERIVATIVE AND MEDICINAL PRODUCT CONTAINING THE SAME.
GB9119920D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
ES2162792T3 (es) * 1991-09-18 2002-01-16 Glaxo Group Ltd Derivados de benzanilida como antagonistas de 5-ht1d.
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
CA2117250C (en) * 1991-10-04 1999-03-02 Atsuro Nakazato Alkoxyphenylalkylamine derivatives
US5486526A (en) * 1992-04-01 1996-01-23 The University Of Toledo Histamine H3 -receptor antagonists and therapeutic uses thereof
EP0566189A1 (en) * 1992-04-13 1993-10-20 Akzo N.V. Psychotropic piperazine derivative
DE69426771T2 (de) * 1993-06-25 2001-06-13 Pola Chemical Industries, Inc. Dopaminreinkorporationshemmer zur behandlung des parkinsonschen syndroms
WO2013086496A2 (en) 2011-12-09 2013-06-13 Research Triangle Institute 1-substituted 4-arylpiperazine as kappa opioid receptor antagonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE564238A (es) *
DE1137733B (de) * 1954-06-05 1962-10-11 Chem Fab Promonta G M B H Verfahren zur Herstellung von Aryl- und Thienylmethylphenylalkylaminen
US2927924A (en) * 1958-04-03 1960-03-08 Lilly Co Eli Novel phenethyl-substituted piperazines
IL48319A0 (en) * 1974-10-26 1975-12-31 Merck Patent Gmbh Araliphatic nitrogen compounds and a process for their preparation
US3997540A (en) * 1975-07-21 1976-12-14 Burroughs Wellcome Co. O [(O-piperazinocarbonyl-phenyl)-thio]-benzoates
US4562201A (en) * 1982-07-26 1985-12-31 American Hospital Supply Corporation Aminomethyl benzanilides
HU196194B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing new 1-4 disubstituted piperazines and pharmaceuticals comprising the compounds
HU196195B (en) * 1986-04-28 1988-10-28 Richter Gedeon Vegyeszet Process for producing 1,4-disubstituted piperazine derivatives and pharmaceuticals comprising the compounds
GB8713061D0 (en) * 1987-06-04 1987-07-08 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
ZA897551B (en) 1990-07-25
PT91932B (pt) 1995-05-31
EP0365064A1 (en) 1990-04-25
FI894783A (fi) 1990-04-11
DK498889D0 (da) 1989-10-09
DK498889A (da) 1990-04-11
NZ230934A (en) 1990-10-26
GR3006821T3 (es) 1993-06-30
IE893129L (en) 1990-04-10
CA2000060A1 (en) 1990-04-10
AU4271389A (en) 1990-04-12
DE68903263D1 (de) 1992-11-26
AU621408B2 (en) 1992-03-12
JPH02134374A (ja) 1990-05-23
PT91932A (pt) 1990-04-30
ATE81651T1 (de) 1992-11-15
EP0365064B1 (en) 1992-10-21
KR900006308A (ko) 1990-05-07
DE68903263T2 (de) 1993-05-19
FI894783A0 (fi) 1989-10-09
US5051424A (en) 1991-09-24

Similar Documents

Publication Publication Date Title
DK114783D0 (da) Hidtil ukendte forbindelser, fremgangsmader til deres fremstilling samt deres anvendelse som laegemidler
DE3881489D1 (de) Peptide mit collagenase hemmender wirkung.
AR017236A1 (es) Compuestos biciclo [2.2.1] heptanos, composiciones farmaceuticas, procedimientos para tratar
ES2032749T3 (es) Acidos oxoftalazinil-aceticos heterociclicos.
NO965305D0 (no) Nye forbindelser, fremgangsmåter ved deres fremstilling og anti-tumormidler
DK0676398T3 (da) Heterocykliske forbindelser, som har antidiabetisk aktivitet, deres fremstilling og deres anvendelse
DK359289A (da) 4-oxoquinolin-3-carboxylsyrederivater og fremgangsmaade til fremstilling deraf samt deres anvendelse
DK116480A (da) Fremgangsmaade til fremstilling af substituerede chromoner
DE69530706D1 (de) Huperzin-derivate, ihre herstellung und ihre verwendung
DE69824025D1 (de) 6,7-asymmetrisch disubstituierte chinoxalincarbonsäurederivate, additionssalze davon und verfahren zur herstellung von beiden
ES2052890T3 (es) Un metodo para la sintesis de compuestos aromaticos di- y trisubstituidos.
FI943508A (fi) Pyridiinikarboksimidamidiyhdisteet ja niiden käyttö
DK26289D0 (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
ATE192141T1 (de) Aromatische hydroxamsäure-verbindungen, ihre herstellung und verwendung
PT911336E (pt) Derivados do acido piridonacarboxilico e intermediarios para a sua sintese
DK0520130T3 (da) Fremgangsmåde til fremstilling af symmetrisk N,N-disubstitueret aromatisk urinstof
PT84206B (pt) Processo para a preparacao de 1,4-di-hidropiridinas
ATE143591T1 (de) Verwendung von bis-(p- hydroxyphenylthio)methanderivaten zur hemmung der fortschreitenden entwicklung von insulinabhängingem diabetes mellitus
ES2192342T3 (es) 2-(2,6-dioxo-3-fluoropiperidin-3-il)-isoindolinas sustituidas y su uso para reducir los niveles de tnfalfa.
ATE189813T1 (de) Prostaglandin-i-analoga
FI882956A (fi) 4-piperidyl-substituerade karboxylsyraderivat och foerfarande foer deras framstaellning.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 365064

Country of ref document: ES